Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia

Atherosclerosis. 2003 Jan;166(1):197-8. doi: 10.1016/s0021-9150(02)00314-3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atorvastatin
  • Cell Adhesion Molecules / drug effects*
  • Cell Adhesion Molecules / physiology
  • Cholesterol, LDL / drug effects*
  • Clinical Trials as Topic
  • Female
  • Heptanoic Acids / pharmacology*
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / physiopathology
  • Male
  • Middle Aged
  • Pyrroles / pharmacology*
  • Pyrroles / therapeutic use

Substances

  • Cell Adhesion Molecules
  • Cholesterol, LDL
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Atorvastatin